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Abstract Primary hypertension is detectable in children and
adolescents and, as in adults, is associated with a positive
family history of hypertension, obesity, and life-style factors.
Owing to the well-established childhood obesity epidemic,
the population prevalence of high blood pressure (BP) in the
young is increasing. Hypertension in childhood is commonly
associated with other cardiovascular risk factors as well as
obesity. Although death and cardiovascular disability do not
occur in hypertensive children, intermediate markers of
target organ damage, such as left ventricular hypertrophy,
thickening of the carotid vessel wall, retinal vascular
changes, and even subtle cognitive changes, are detectable
in children and adolescents with high BP. Considering the
rates of verified hypertension (>3%) and pre-hypertension
(>3%) in asymptomatic children and adolescents, high BP
should be considered a common long-term health problem in
childhood.
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Introduction
Hypertension is a major long-term health condition and is the
leading cause of premature death among adults throughout the
world, including both developed, developing, and lesser
developed countries [1]. Primary hypertension emerges from
a complex inter-play of genetic, environmental, and behav-
ioral factors. Owing to the hereditary component of
hypertension, the disorder is considered to have its origins
in the young [2]. It is now established that hypertension is
detectable in children and adolescents and is not uncommon.
Population changes in health-related behaviors, including the
childhood obesity epidemic, indicate that the rates of
hypertension in the young are increasing [3]. Several
challenges regarding hypertension now confront clinicians
who care for children and adolescents and include detecting
hypertension, distinguishing secondary hypertension from
primary hypertension, examining patients for hypertension-
related risk factors and target organ damage, applying
interventions to control blood pressure (BP), and encourag-
ing preventive lifestyles. This review discusses the epidemi-
ology and natural history of primary hypertension in children
and adolescents.
Normative blood pressure data
The definition of hypertension in adults is based on the
approximate level of BP that marks an increase in
cardiovascular events and death. Several expert panels have
defined hypertension in adults as systolic pressure ≥
140 mmHg or diastolic pressure ≥ 90 mmHg [4–6]. These
are the approximate BP levels above which the risks for
morbid events is significantly heightened and the benefits
of treatment are established. However, it is now recognized that
the risk for cardiovascular events attributable to BP level in
adults does not begin at 140/90 mmHg but is linear, and that
the risk begins to rise at BP levels below 140/90 mmHg. For
BP levels greater than 115/75 mmHg, the risk for
hypertension-related events doubles with each 20 mmHg
increase in systolic pressure or each 10 mmHg increase in
Pediatr Nephrol (2010) 25:1219–1224
DOI 10.1007/s00467-009-1200-3
B. Falkner (*)
Pediatrics and Medicine, Thomas Jefferson University,
833 Chestnut Street, Suite 700,
Philadelphia, PA 19107, USA
e-mail: Bonita.Falkner@jefferson.edu
diastolic BP [7]. Based on these findings in adults,
pre-hypertension is defined in adults as systolic BP between
120 mmHg and 139 mmHg or diastolic BP between 80 mmHg
and 89 mmHg, and lifestyle changes to prevent or delay
progression to hypertension are recommended [1].
The definition of hypertension in adults is based on, and
supported by, outcome data. Similar data to define
hypertension in childhood that are based on risk for events
in adult years are not available. Master et al. [8] published a
report in 1950 that challenged the use of a single number to
define hypertension in adults. They contended that an
increase in BP was a reflection of aging and that
hypertension was over-diagnosed in the elderly. Because
BP, like most human characteristics, demonstrates a
frequency distribution that yields a fairly normal curve,
they proposed that BP that reached a level that was two
standard deviations beyond the statistical mean, or greater
than the 95th percentile, should be considered abnormal.
Using a statistical method to define the normal range of BP,
they described the normal range of systolic BP in young
men to be 105–135 mmHg at age 16 years, rising
progressively with age to reach 115–170 mmHg at age
60–65 years. They also noted a gender difference in the
normal range of BP, with lower levels in younger women
than in younger men. A large body of subsequent
epidemiological and clinical investigations on hypertension
in adults has clearly dismissed the conclusion by Master et
al. that hypertension should be statistically defined in
adults. However, their report was the earliest to show that
the normal range of BP is lower in persons aged 16–
19 years than that in early adulthood, and gender differ-
ences were also identified. Of most significance is that their
report provided a statistical method to define the normal BP
range, and abnormal BP could be defined in the absence of
mortality or morbidity end points.
The early efforts to describe the normal range BP
according to age throughout childhood reported markedly
different results [9]. In a recent analysis, Din-Dzietham et
al. [10] applied the 95th percentile definition of high BP,
based on the most current BP percentile tables, published in
2004 [2], to the data from the early surveys on children’s
BP. As shown in their report, in using the current BP level
for the 95th percentile (by age and gender), they found that
the rates of high BP in the earlier surveys were astonish-
ingly high. According to current BP levels for the 95th
percentile, the overall estimated prevalence of high BP
among children in the 1963–1970 survey would have been
37.2%; in the 1971–1975 survey it decreased to 16.9%; in
the 1976–1980 it decreased to 11.1%. By 1982–1984 the
prevalence was 4.7%, and the lowest was 2.7% in the 1988–
1994 survey. The earliest childhood BP surveys were, in
general, based on a single BP measurement, and a
standardized method for BP measurement was not uniformly
applied. It is unlikely that the prevalence of high BP was so
high in 1963 and that the prevalence would have changed so
drastically from 1963 to 1994. What changed was the body of
normative BP data from which the BP percentiles were derived
[11]. The need to obtain a larger body of data on BP in the
young within the context of childhood growth was recognized
by the National Heart, Lung, and Blood Institute (NHLBI) in
the 1970s. The NHLBI subsequently supported several
epidemiological studies that prospectively investigated BP
and growth in children and adolescents. These projects were
conducted at several sites and enrolled representative samples
of children and adolescents. Rigorous detail was applied to the
methodology of BP measurement. Growth and development
measures were obtained, and BP level was examined relative
to physiological development. This collective body of child-
ren’s BP data provided the data on BP distribution reported in
the second Task Force on Blood Pressure in Children and
Adolescents [12]. Subsequently, there was little shift in the
distribution of children’s BP [13] until the recent upward trend
attributed to the rising rates of childhood obesity [3, 10].
Rather than a single BP level, the top portion of the
distribution of BP specific to age, gender, and height
continues to be used to define high BP throughout
childhood. Hypertension in childhood is defined as systolic
and/or diastolic BP that is ≥95th percentile for age, gender,
and height. Previously, children with BP levels ≥90th
percentile but <95th percentile were termed high normal.
To be consistent with adult terms, and the concept that BP
risks are linear rather than categorical, this term been
changed to pre-hypertension. Therefore, pre-hypertension is
defined as systolic and/or diastolic BP that is >90th
percentile (for age, gender, and height) but <95th percen-
tile. However, this designation remains arbitrary and
without supportive childhood evidence. Moreover, in
adolescence, the 90th percentile is often higher than the
adult threshold for pre-hypertension of 120/80 mmHg.
Therefore, beginning for children aged 12 years, pre-
hypertension is defined as BP levels in the range of 120/
80 mmHg to the 95th percentile. The rationale for this
definition is based on the findings that the risk for events in
adults begins to rise at a BP level above 115/75 mmHg,
and that, for clinical purposes, adolescents could benefit
from preventive lifestyle interventions as well as adults. BP
levels that are consistently above the 95th percentile are
staged for severity. Stage 1 hypertension is defined as an
average BP level from the 95th percentile to 5 mmHg
above the 99th percentile. Stage 2 hypertension is defined
as an average BP that exceeds 5 mmHg above the 99th
percentile. Owing to BP variability within individual
patients, in clinical practice the diagnoses of hypertension
and pre-hypertension require repeated measurements [2]. In
adults the diagnosis of hypertension is verified by BP ≥140/
90 mmHg on two separate visits. To avoid over-diagnosis
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of hypertension in a child with a single elevated BP, three
separate visits for BP measurement are recommended, with
an average BP ≥95th percentile required for diagnosis of
hypertension. An exception to the necessity for repeated BP
measurement would be stage 2 hypertension or a child with
symptomatic hypertension.
In other countries the BP percentile level that is used to
define high BP in children varies somewhat from the US
definitions described above. High BP in the UK is defined
as BP above the 98th percentile for age [14]. BP reference
values have also been reported in Northern Europe [15] and
Asia [16]. These reports describe a slightly higher BP level
at the 95th percentile. However, all epidemiological reports
on normative childhood BP data demonstrate a consistent
and significant relationship of BP with age, height, and
body weight throughout childhood.
Prevalence of childhood hypertension
The prevalence of pediatric hypertension worldwide is not
known, due to regional differences in the definition of high
BP, the distribution of reference BP data, and the BP
measurement methodology. Based on the use of ≥95th
percentile to define hypertension, it would be expected that
the prevalence of hypertension would be approximately
5%. However, due to the effects of accommodation and
regression to the mean with repeated measures, the
prevalence of hypertension is lower than 5% and had been
expected to be from 1–3% following the recommended
three separate measurements in children with an initial BP
measurement ≥95th percentile.
Recent reports have provided a more precise estimate of
the prevalence of hypertension verified by separate meas-
urements. In a recent study Hansen et al. [17] applied the
above criteria for hypertension and pre-hypertension to
electronic medical record data from well-child care visits in
a cohort of over 14,000 primary care patients. With the
advantage of having data on repeat BP measurements on
separate visits, these investigators determined the prevalence
of hypertension to be 3.6% and the prevalence of pre-
hypertension to be 3.4% in children and adolescents between
the ages of 3 years and 18 years. In a cross-sectional study
limited to the adolescence age, the prevalence of pre-
hypertension and hypertension was determined in a cohort
of 6,790 high school students (11–17 years). Using the
recommended repeated BP measurements on those with an
elevated initial BP measurement, the authors found that the
prevalence of hypertension was 3.2% and the prevalence of
pre-hypertension was 15.7% in adolescence [18]. In both
reports the presence of obesity was associated with higher
rates of high BP. In the study on high school students by
McNiece et al. [18] the prevalence of hypertension and pre-
hypertension combined was over 30% in obese boys and
from 23–30% in obese girls, depending on ethnicity.
The current childhood obesity epidemic [19] and the
strong relationship of BP with body weight indicate that the
population prevalence of high BP in the young will
increase. The epidemiologic evidence to support an adverse
impact of childhood obesity on child BP levels has been
questioned because, as discussed previously, the earlier
population data on children’s BP (from the 1963–1984)
described considerably higher BP values than in the data
obtained after 1984 [20]. When the entirety of the data from
the children’s BP survey from 1963 to 1994 is compared,
it would appear that children’s BP levels are decreasing,
despite an increase in child obesity within the past decade.
However, the variable methods used in the earlier BP
surveys limit the ability for us to define a longitudinal trend
in children’s BP over several decades. An analysis of the
trends in childhood BP from two more recent studies by the
National Health and Nutrition Examination Surveys
(NHANES) group, which were sequential, national and
cross-sectional, identified a significant increase in both
systolic and diastolic BPs. The BP increase is most striking
among minority groups that also have the highest rates of
childhood obesity [3]. Another analysis of the same two data
cohorts demonstrated an overall increase in the prevalence of
hypertension, from 2.7% in the 1988–1994 survey to 3.7%
in the 1999–2002 survey [10]. Both analyses verified that the
population increase in BP among children and adolescents
was largely due to the increase in obesity.
Incidence of hypertension in childhood
Among adults, the prevalence of hypertension increases
with age, indicating that new cases of hypertension in
adults are diagnosed each year. Although primary hyper-
tension is more commonly identified in adolescence than
earlier in childhood, there is little information about the
incident rates of hypertension in childhood. Within the
National Childhood Blood Pressure database, a segment of
adolescents underwent BP measurement at intervals of 2 years
and 4 years. An analysis of these data found that, among
adolescents with pre-hypertension, 14% had developed
hypertension 2 years later, which yielded an approximate
incidence rate of 7% per year. A limitation of these data is that
they were based on only a single blood pressure measurement
for BP classification. Despite this limitation, the serial data
indicate that those with high BP continue to have high BP.
Among adolescents with high risk BP values, including those
designated from a single measurement as having pre-
hypertension and hypertension combined, 68% of boys and
43% of girls had developed pre-hypertension or hypertension
2 years later [21].
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Despite the well-known variability in serial BP measure-
ments in children, there is now substantial evidence that BP
measured in childhood predicts future BP. Those with BP
levels in the higher portions of the distribution curve tend to
maintain that position over time which is indicative of BP
tracking [22]. For example, a community study of 1,505
children aged 5–14 years demonstrated tracking of systolic
and diastolic BPs over 15 years, with statistically significant
correlation coefficients between childhood BP and later BP
levels. Of 116 young adult participants who had developed
hypertension, 48% and 41% had suffered elevated childhood
systolic and diastolic BPs, respectively [23]. The patterns
may vary by race, but weight does not seem to affect
population tracking data significantly [24, 25].
A recent systematic review and analysis of 50 cohort
studies that examined BP tracking documented significant
BP tracking correlation coefficients from childhood into
adulthood. The strength of the tracking increased with
baseline age and decreased with length of follow-up period.
The analysis concluded that data from diverse populations
show that the evidence for BP tracking from childhood into
adulthood is strong and that early intervention is important
[26]. In another study Sun et al. [27] examined serial data
from participants in the Fels Longitudinal Study and
derived age- and gender-specific BP levels in childhood
that predicted hypertension in adulthood. Using random-
effects models they found that the earliest significant
difference in childhood systolic BP values among adults
with and without hypertension occurred at age 5 years for
boys and 8 years for girls. The interesting finding from this
study was the level of childhood BP that was predictive of
subsequent hypertension in adults. The age- and gender-
specific values for childhood systolic BP among adults with
hypertension were below the 50th percentile for systolic BP
in children of median height, based on data in the Fourth
report on diagnosis, evaluation, and treatment of high blood
pressure in children and adolescents [2]. Therefore, the
childhood systolic BP values in the Fels Longitudinal Study
that were predictive of future hypertension in adults were
well below childhood BP levels that are presently considered
to be high risk. These results raise the question of whether
the 95th percentile or the 90th percentile for BP in childhood
adequately captures high risk BP.
Outcomes of childhood onset hypertension
There are presently no long-term data to connect a level of
childhood BP with cardiovascular events in later adulthood.
Despite the absence of such longitudinal data to assess
outcome risk among adolescents with high BP, data on
surrogate markers of vascular injury indicate that vascular
abnormality does occur even in the young. Left ventricular
hypertrophy (LVH) occurs commonly in children and
adolescents with high BP [28–31]. Among children and
adolescents with primary hypertension, the presence of
obesity was associated with marked LVH [28]. Structural
changes in forearm vessels of obese adolescents with high
BP were detected by Rocchini et al. [32], who observed a
significant correlation between peripheral vascular resis-
tance at maximum vasodilation and measures of insulin
resistance. Carotid artery intimal medial thickness (cIMT),
assessed by ultrasound, has been found to be greater in
young adults who had had multiple risk factors since
childhood [33–35]. In a smaller cross-sectional study an
increase in cIMT was already detectable in adolescents with
high BP [36]. Microalbuminuria predicts progressive deterio-
ration of renal function and an increased risk of cardiovascular
(CV) events/death in adults. Recently, Assadi demonstrated
that, in children with essential hypertension, the treatment of
microalbuminuria by renoprotective therapy (angiotensin-
converting enzyme inhibitors or angiotensin-receptor block-
ers) was associated with LVH regression [37]. The Pathologic
Determinants of Atherosclerosis in Youth study, based on
autopsies of individuals that had suffered accidental death,
demonstrated that quantifiable vessel injury is detectable in
adolescents and young adults; and there is a relationship, even
in youth, between early atherosclerotic lesions and cardiovas-
cular risk factors, including high BP, altered lipids, and
smoking exposure [38, 39]. In a recent study by Mitchell et al.
[40] digital retinal photographs were used to measure retinal
arteriolar caliber in children. The investigators observed that
children in the highest quartile of BP had significantly
narrower retinal arterioles than those with lower BP, suggest-
ing that higher BP in childhood is associated with alteration in
the microvasculature. There is even emerging evidence that
cognitive function is adversely affected by elevated blood
pressure in childhood [41, 42].
Summary
It is well established that high BP can be identified in
children and adolescents [2], and is increasing in prevalence
[3, 10]. However, the definition of hypertension continues
to be based on the upper segment of the normal BP
distribution and not on outcome data. It is quite possible
that the percentiles currently used to define hypertension
and pre-hypertension in childhood underestimate the
longitudinal risk; and future evidence may warrant a lower
level to define high risk BP. Despite the meticulous
precision in the BP tables, which adjust for gender, age,
and height, the percentile method for the evaluation of BP
in children is cumbersome and difficult to use in clinical
practice. It would be an extremely useful clinical practice
advancement if a few numerical levels could be reliably
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used for the evaluation of children’s BP. However, for one
to be certain of what BP value is abnormal, there needs to
be clear evidence on where the abnormality begins. What is
clear is that more BP measurements on an individual child
provide a better definition of the BP phenotype. Ambula-
tory BP monitoring (ABPM) has become a useful tool for
evaluating BP patterns in children, and some normative
ABPM data are now available. Because ABPM is
performed over 24 hours and requires special instrumenta-
tion, its use has been generally limited to hypertension
specialists. Recommendations on the use of ABPM in
clinical practice and interpretation of the results have been
published recently in a scientific statement from the
American Heart Association [43].
Data from clinical studies on high BP in childhood show
that primary hypertension in childhood is commonly
associated with other cardiovascular risk factors as well as
obesity. It is also apparent that intermediate markers of
target organ damage, such as LVH, increased cIMT, retinal
vascular changes, and even subtle cognitive changes, are
detectable in children and adolescents with high BP.
Considering the rates of verified hypertension (>3%) and
pre-hypertension (>3%) in asymptomatic children and
adolescents, we should consider high BP as a common
long-term health problem in childhood. For both clinical
and public health benefit, identification, examination, and
treatment of children with high risk BP is an important step
in reducing the excessive burden of cardiovascular disease.
Questions
(Answers appear following the reference list)
1. Hypertension is defined in adolescents as:
a. Average BP ≥ 140/90 mmHg
b. Average BP ≥ 120/80 mmHg
c. Average BP ≥ 95th percentile
d. Average BP ≥ 90th percentile
2. The definition of hypertension in children and adolescents
is based on:
a. The top portion of the normal distribution of BP
levels in healthy children
b. Outcome data
c. Evidence of target organ damage
d. Two additional cardiovascular risk factors
3. A single BP measurement of 136/74 mmHg in an
asymptomatic 12 year old boy indicates:
a. Essential hypertension
b. Need for repeat BP measurement
c. Probable secondary hypertension
d. Risk for cardiovascular disease
4. The prevalence of hypertension in asymptomatic
children and adolescents is approximately:
a. <1%
b. 3.5%
c. 5%
d. 10%
5. A recent increase in prevalence of childhood hypertension
is most related to:
a. Improved methods of BP measurement
b. Changes in diet and food supply
c. Ethnic shifts in the population
d. Childhood obesity
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